0.009204 0.005314 0.000000 0.000000 0.010627 0.000000 0.000000 0.000000 0.020245 0.00000 0.00000 0.00000 Rice, K.D. Aay, N. Anand, N.K. Blazey, C.M. Bowles, O.J. Bussenius, J. Costanzo, S. Curtis, J.K. Defina, S.C. Dubenko, L. Engst, S. Joshi, A.A. Kennedy, A.R. Kim, A.I. Koltun, E.S. Lougheed, J.C. Manalo, J.C.L. Martini, J.F. Nuss, J.M. Peto, C.J. Tsang, T.H. Yu, P. Johnston, S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 6 90.00 90.00 120.00 108.653 108.653 49.394 C16 H12 F3 I N2 O2 448.178 [3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-(3-OXIDANYLAZETIDIN-1-YL)METHANONE non-polymer C11 H18 N5 O12 P3 505.208 PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking Mg 2 24.305 MAGNESIUM ION non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Acs Med.Chem.Lett. 1948-5875 3 416 10.1021/ML300049D 24900486 Novel Carboxamide-Based Allosteric Mek Inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973) 2012 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 FLAT MIRROR, RH COATED CCD 2005-05-10 ADSC QUANTUM 315r SI(311) SINGLE WAVELENGTH M x-ray 1 0.97946 1.0 BL9-1 SSRL 0.97946 SYNCHROTRON SSRL BEAMLINE BL9-1 DELETION OF AMINO ACID RESIDUES 263-304 33614.730 DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 2.7.12.2 PROTEIN KINASE DOMAIN, RESIDUES 61-262,305-392 YES 1 man polymer 505.208 PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER 1 syn non-polymer 24.305 MAGNESIUM ION 1 syn non-polymer 448.178 [3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-(3-OXIDANYLAZETIDIN-1-YL)METHANONE 1 syn non-polymer 18.015 water 5 nat water MAP KINASE KINASE 1, MAPKK 1, MKK1, ERK ACTIVATOR KINASE 1, MAPK/ERK KINASE 1, MEK 1 no no MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVN KCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGEGHHHHHH MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVN KCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGEGHHHHHH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN FALL ARMYWORM sample 9606 HOMO SAPIENS 7108 SPODOPTERA FRUGIPERDA SF9 BACULOVIRUS 1 2.32 47 NONE VAPOR DIFFUSION, SITTING DROP 8.9 SITTING DROP VAPOR-DIFFUSION VS. 26.5 % PEG-2000 MME, 0.1 M TRIMETHYLAMINE N-OXIDE, 0.1 M TRIS (PH 8.9) pdbx_struct_conn_angle struct_conn struct_conn_type exptl_crystal_grow repository Initial release Database references Data collection Derived calculations Data collection Experimental preparation 1 0 2012-12-19 1 1 2014-06-18 1 2 2018-06-20 1 3 2019-05-08 _pdbx_struct_conn_angle.ptnr1_auth_comp_id _pdbx_struct_conn_angle.ptnr1_auth_seq_id _pdbx_struct_conn_angle.ptnr1_label_asym_id _pdbx_struct_conn_angle.ptnr1_label_atom_id _pdbx_struct_conn_angle.ptnr1_label_comp_id _pdbx_struct_conn_angle.ptnr1_label_seq_id _pdbx_struct_conn_angle.ptnr3_auth_comp_id _pdbx_struct_conn_angle.ptnr3_auth_seq_id _pdbx_struct_conn_angle.ptnr3_label_asym_id _pdbx_struct_conn_angle.ptnr3_label_atom_id _pdbx_struct_conn_angle.ptnr3_label_comp_id _pdbx_struct_conn_angle.ptnr3_label_seq_id _pdbx_struct_conn_angle.value _exptl_crystal_grow.method X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEINKINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973), OR RELATED ANALOGS. CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973), OR RELATED ANALOGS. CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973), OR RELATED ANALOGS. PDBE Y PDBE 2012-03-16 REL ACP PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER MG MAGNESIUM ION 2P7 [3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-(3-OXIDANYLAZETIDIN-1-YL)METHANONE HOH water ACP 1382 2 ACP ACP 1382 A MG 1383 3 MG MG 1383 A 2P7 1384 4 2P7 2P7 1384 A HOH 2001 5 HOH HOH 2001 A HOH 2002 5 HOH HOH 2002 A HOH 2003 5 HOH HOH 2003 A HOH 2004 5 HOH HOH 2004 A HOH 2005 5 HOH HOH 2005 A MET 58 n 1 MET 58 A ALA 59 n 2 ALA 59 A LEU 60 n 3 LEU 60 A GLY 61 n 4 GLY 61 A GLU 62 n 5 GLU 62 A LEU 63 n 6 LEU 63 A LYS 64 n 7 LYS 64 A ASP 65 n 8 ASP 65 A ASP 66 n 9 ASP 66 A ASP 67 n 10 ASP 67 A PHE 68 n 11 PHE 68 A GLU 69 n 12 GLU 69 A LYS 70 n 13 LYS 70 A ILE 71 n 14 ILE 71 A SER 72 n 15 SER 72 A GLU 73 n 16 GLU 73 A LEU 74 n 17 LEU 74 A GLY 75 n 18 GLY 75 A ALA 76 n 19 ALA 76 A GLY 77 n 20 GLY 77 A ASN 78 n 21 ASN 78 A GLY 79 n 22 GLY 79 A GLY 80 n 23 GLY 80 A VAL 81 n 24 VAL 81 A VAL 82 n 25 VAL 82 A PHE 83 n 26 PHE 83 A LYS 84 n 27 LYS 84 A VAL 85 n 28 VAL 85 A SER 86 n 29 SER 86 A HIS 87 n 30 HIS 87 A LYS 88 n 31 LYS 88 A PRO 89 n 32 PRO 89 A SER 90 n 33 SER 90 A GLY 91 n 34 GLY 91 A LEU 92 n 35 LEU 92 A VAL 93 n 36 VAL 93 A MET 94 n 37 MET 94 A ALA 95 n 38 ALA 95 A ARG 96 n 39 ARG 96 A LYS 97 n 40 LYS 97 A LEU 98 n 41 LEU 98 A ILE 99 n 42 ILE 99 A HIS 100 n 43 HIS 100 A LEU 101 n 44 LEU 101 A GLU 102 n 45 GLU 102 A ILE 103 n 46 ILE 103 A LYS 104 n 47 LYS 104 A PRO 105 n 48 PRO 105 A ALA 106 n 49 ALA 106 A ILE 107 n 50 ILE 107 A ARG 108 n 51 ARG 108 A ASN 109 n 52 ASN 109 A GLN 110 n 53 GLN 110 A ILE 111 n 54 ILE 111 A ILE 112 n 55 ILE 112 A ARG 113 n 56 ARG 113 A GLU 114 n 57 GLU 114 A LEU 115 n 58 LEU 115 A GLN 116 n 59 GLN 116 A VAL 117 n 60 VAL 117 A LEU 118 n 61 LEU 118 A HIS 119 n 62 HIS 119 A GLU 120 n 63 GLU 120 A CYS 121 n 64 CYS 121 A ASN 122 n 65 ASN 122 A SER 123 n 66 SER 123 A PRO 124 n 67 PRO 124 A TYR 125 n 68 TYR 125 A ILE 126 n 69 ILE 126 A VAL 127 n 70 VAL 127 A GLY 128 n 71 GLY 128 A PHE 129 n 72 PHE 129 A TYR 130 n 73 TYR 130 A GLY 131 n 74 GLY 131 A ALA 132 n 75 ALA 132 A PHE 133 n 76 PHE 133 A TYR 134 n 77 TYR 134 A SER 135 n 78 SER 135 A ASP 136 n 79 ASP 136 A GLY 137 n 80 GLY 137 A GLU 138 n 81 GLU 138 A ILE 139 n 82 ILE 139 A SER 140 n 83 SER 140 A ILE 141 n 84 ILE 141 A CYS 142 n 85 CYS 142 A MET 143 n 86 MET 143 A GLU 144 n 87 GLU 144 A HIS 145 n 88 HIS 145 A MET 146 n 89 MET 146 A ASP 147 n 90 ASP 147 A GLY 148 n 91 GLY 148 A GLY 149 n 92 GLY 149 A SER 150 n 93 SER 150 A LEU 151 n 94 LEU 151 A ASP 152 n 95 ASP 152 A GLN 153 n 96 GLN 153 A VAL 154 n 97 VAL 154 A LEU 155 n 98 LEU 155 A LYS 156 n 99 LYS 156 A LYS 157 n 100 LYS 157 A ALA 158 n 101 ALA 158 A GLY 159 n 102 GLY 159 A ARG 160 n 103 ARG 160 A ILE 161 n 104 ILE 161 A PRO 162 n 105 PRO 162 A GLU 163 n 106 GLU 163 A GLN 164 n 107 GLN 164 A ILE 165 n 108 ILE 165 A LEU 166 n 109 LEU 166 A GLY 167 n 110 GLY 167 A LYS 168 n 111 LYS 168 A VAL 169 n 112 VAL 169 A SER 170 n 113 SER 170 A ILE 171 n 114 ILE 171 A ALA 172 n 115 ALA 172 A VAL 173 n 116 VAL 173 A ILE 174 n 117 ILE 174 A LYS 175 n 118 LYS 175 A GLY 176 n 119 GLY 176 A LEU 177 n 120 LEU 177 A THR 178 n 121 THR 178 A TYR 179 n 122 TYR 179 A LEU 180 n 123 LEU 180 A ARG 181 n 124 ARG 181 A GLU 182 n 125 GLU 182 A LYS 183 n 126 LYS 183 A HIS 184 n 127 HIS 184 A LYS 185 n 128 LYS 185 A ILE 186 n 129 ILE 186 A MET 187 n 130 MET 187 A HIS 188 n 131 HIS 188 A ARG 189 n 132 ARG 189 A ASP 190 n 133 ASP 190 A VAL 191 n 134 VAL 191 A LYS 192 n 135 LYS 192 A PRO 193 n 136 PRO 193 A SER 194 n 137 SER 194 A ASN 195 n 138 ASN 195 A ILE 196 n 139 ILE 196 A LEU 197 n 140 LEU 197 A VAL 198 n 141 VAL 198 A ASN 199 n 142 ASN 199 A SER 200 n 143 SER 200 A ARG 201 n 144 ARG 201 A GLY 202 n 145 GLY 202 A GLU 203 n 146 GLU 203 A ILE 204 n 147 ILE 204 A LYS 205 n 148 LYS 205 A LEU 206 n 149 LEU 206 A CYS 207 n 150 CYS 207 A ASP 208 n 151 ASP 208 A PHE 209 n 152 PHE 209 A GLY 210 n 153 GLY 210 A VAL 211 n 154 VAL 211 A SER 212 n 155 SER 212 A GLY 213 n 156 GLY 213 A GLN 214 n 157 GLN 214 A LEU 215 n 158 LEU 215 A ILE 216 n 159 ILE 216 A ASP 217 n 160 ASP 217 A GLU 218 n 161 GLU 218 A MET 219 n 162 MET 219 A ALA 220 n 163 ALA 220 A ASN 221 n 164 ASN 221 A GLU 222 n 165 GLU 222 A n 166 223 A VAL 224 n 167 VAL 224 A GLY 225 n 168 GLY 225 A THR 226 n 169 THR 226 A ARG 227 n 170 ARG 227 A SER 228 n 171 SER 228 A TYR 229 n 172 TYR 229 A MET 230 n 173 MET 230 A SER 231 n 174 SER 231 A PRO 232 n 175 PRO 232 A GLU 233 n 176 GLU 233 A ARG 234 n 177 ARG 234 A LEU 235 n 178 LEU 235 A GLN 236 n 179 GLN 236 A GLY 237 n 180 GLY 237 A THR 238 n 181 THR 238 A HIS 239 n 182 HIS 239 A TYR 240 n 183 TYR 240 A SER 241 n 184 SER 241 A VAL 242 n 185 VAL 242 A GLN 243 n 186 GLN 243 A SER 244 n 187 SER 244 A ASP 245 n 188 ASP 245 A ILE 246 n 189 ILE 246 A TRP 247 n 190 TRP 247 A SER 248 n 191 SER 248 A MET 249 n 192 MET 249 A GLY 250 n 193 GLY 250 A LEU 251 n 194 LEU 251 A SER 252 n 195 SER 252 A LEU 253 n 196 LEU 253 A VAL 254 n 197 VAL 254 A GLU 255 n 198 GLU 255 A MET 256 n 199 MET 256 A ALA 257 n 200 ALA 257 A VAL 258 n 201 VAL 258 A GLY 259 n 202 GLY 259 A ARG 260 n 203 ARG 260 A TYR 261 n 204 TYR 261 A PRO 262 n 205 PRO 262 A ARG 305 n 206 ARG 305 A PRO 306 n 207 PRO 306 A PRO 307 n 208 PRO 307 A MET 308 n 209 MET 308 A ALA 309 n 210 ALA 309 A ILE 310 n 211 ILE 310 A PHE 311 n 212 PHE 311 A GLU 312 n 213 GLU 312 A LEU 313 n 214 LEU 313 A LEU 314 n 215 LEU 314 A ASP 315 n 216 ASP 315 A TYR 316 n 217 TYR 316 A ILE 317 n 218 ILE 317 A VAL 318 n 219 VAL 318 A ASN 319 n 220 ASN 319 A GLU 320 n 221 GLU 320 A PRO 321 n 222 PRO 321 A PRO 322 n 223 PRO 322 A PRO 323 n 224 PRO 323 A LYS 324 n 225 LYS 324 A LEU 325 n 226 LEU 325 A PRO 326 n 227 PRO 326 A SER 327 n 228 SER 327 A ALA 328 n 229 ALA 328 A VAL 329 n 230 VAL 329 A PHE 330 n 231 PHE 330 A SER 331 n 232 SER 331 A LEU 332 n 233 LEU 332 A GLU 333 n 234 GLU 333 A PHE 334 n 235 PHE 334 A GLN 335 n 236 GLN 335 A ASP 336 n 237 ASP 336 A PHE 337 n 238 PHE 337 A VAL 338 n 239 VAL 338 A ASN 339 n 240 ASN 339 A LYS 340 n 241 LYS 340 A CYS 341 n 242 CYS 341 A LEU 342 n 243 LEU 342 A ILE 343 n 244 ILE 343 A LYS 344 n 245 LYS 344 A ASN 345 n 246 ASN 345 A PRO 346 n 247 PRO 346 A ALA 347 n 248 ALA 347 A GLU 348 n 249 GLU 348 A ARG 349 n 250 ARG 349 A ALA 350 n 251 ALA 350 A ASP 351 n 252 ASP 351 A LEU 352 n 253 LEU 352 A LYS 353 n 254 LYS 353 A GLN 354 n 255 GLN 354 A LEU 355 n 256 LEU 355 A MET 356 n 257 MET 356 A VAL 357 n 258 VAL 357 A HIS 358 n 259 HIS 358 A ALA 359 n 260 ALA 359 A PHE 360 n 261 PHE 360 A ILE 361 n 262 ILE 361 A LYS 362 n 263 LYS 362 A ARG 363 n 264 ARG 363 A SER 364 n 265 SER 364 A ASP 365 n 266 ASP 365 A ALA 366 n 267 ALA 366 A GLU 367 n 268 GLU 367 A GLU 368 n 269 GLU 368 A VAL 369 n 270 VAL 369 A ASP 370 n 271 ASP 370 A PHE 371 n 272 PHE 371 A ALA 372 n 273 ALA 372 A GLY 373 n 274 GLY 373 A TRP 374 n 275 TRP 374 A LEU 375 n 276 LEU 375 A CYS 376 n 277 CYS 376 A SER 377 n 278 SER 377 A THR 378 n 279 THR 378 A ILE 379 n 280 ILE 379 A GLY 380 n 281 GLY 380 A LEU 381 n 282 LEU 381 A n 283 382 A n 284 383 A n 285 384 A n 286 385 A n 287 386 A n 288 387 A n 289 388 A n 290 389 A n 291 390 A n 292 391 A n 293 392 A n 294 393 A n 295 394 A n 296 395 A n 297 396 A n 298 397 A n 299 398 A n 300 399 A n 301 400 A author_and_software_defined_assembly PISA 1 monomeric A ASN 195 A OD1 ASN 138 1_555 A MG 1383 C MG MG 1_555 A ASP 208 A OD2 ASP 151 1_555 80.5 A ASN 195 A OD1 ASN 138 1_555 A MG 1383 C MG MG 1_555 A ACP 1382 B O1B ACP 1_555 92.6 A ASP 208 A OD2 ASP 151 1_555 A MG 1383 C MG MG 1_555 A ACP 1382 B O1B ACP 1_555 155.3 A ASN 195 A OD1 ASN 138 1_555 A MG 1383 C MG MG 1_555 A ACP 1382 B O1A ACP 1_555 144.2 A ASP 208 A OD2 ASP 151 1_555 A MG 1383 C MG MG 1_555 A ACP 1382 B O1A ACP 1_555 94.5 A ACP 1382 B O1B ACP 1_555 A MG 1383 C MG MG 1_555 A ACP 1382 B O1A ACP 1_555 77.3 A ASN 195 A OD1 ASN 138 1_555 A MG 1383 C MG MG 1_555 A HOH 2003 E O HOH 1_555 75.1 A ASP 208 A OD2 ASP 151 1_555 A MG 1383 C MG MG 1_555 A HOH 2003 E O HOH 1_555 86.9 A ACP 1382 B O1B ACP 1_555 A MG 1383 C MG MG 1_555 A HOH 2003 E O HOH 1_555 68.4 A ACP 1382 B O1A ACP 1_555 A MG 1383 C MG MG 1_555 A HOH 2003 E O HOH 1_555 69.2 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLY 77 A N GLY 20 A O GLY 80 A O GLY 23 A N VAL 85 A N VAL 28 A O MET 94 A O MET 37 A N ILE 99 A N ILE 42 A O ILE 139 A O ILE 82 A O CYS 142 A O CYS 85 A N TYR 130 A N TYR 73 A N ASN 199 A N ASN 142 A O GLU 203 A O GLU 146 1 A PHE 223 A PHE 166 1 Y 1 A ASN 382 A ASN 283 1 Y 1 A GLN 383 A GLN 284 1 Y 1 A PRO 384 A PRO 285 1 Y 1 A SER 385 A SER 286 1 Y 1 A THR 386 A THR 287 1 Y 1 A PRO 387 A PRO 288 1 Y 1 A THR 388 A THR 289 1 Y 1 A HIS 389 A HIS 290 1 Y 1 A ALA 390 A ALA 291 1 Y 1 A ALA 391 A ALA 292 1 Y 1 A GLY 392 A GLY 293 1 Y 1 A GLU 393 A GLU 294 1 Y 1 A GLY 394 A GLY 295 1 Y 1 A HIS 395 A HIS 296 1 Y 1 A HIS 396 A HIS 297 1 Y 1 A HIS 397 A HIS 298 1 Y 1 A HIS 398 A HIS 299 1 Y 1 A HIS 399 A HIS 300 1 Y 1 A HIS 400 A HIS 301 1 Y 1 A PRO 262 17.64 1 -15.02 1.60 122.70 107.68 A A A O C N PRO PRO ARG 262 262 305 Y 1 A A C N PRO ARG 262 305 0.190 0.023 1.336 1.526 Y 1 A A CB SG CYS CYS 341 341 -0.103 0.016 1.812 1.709 N 1 A PRO 105 -19.78 -52.78 1 A ASP 136 28.19 64.61 1 A ASP 147 -47.29 -2.54 1 A HIS 184 -142.96 -8.87 1 A ARG 189 90.36 -23.63 1 A ASP 190 -154.69 65.34 1 A ASP 208 72.25 33.73 1 A ALA 220 -58.72 8.00 1 A THR 226 -63.03 65.46 1 A GLN 236 -66.21 18.80 1 A PRO 262 -72.65 32.75 1 A ALA 359 -21.64 -59.58 50.373 -2.92 -1.46 0.00 -2.92 0.00 4.38 0.936 0.850 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 0.31259 0.19974 0.20522 2.80 49.40 429 7922 5.1 99.67 17.670 0.353 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 0.476 0.80 0.80 1.20 UNPUBLISHED MEK1-ATP COMPLEX MAXIMUM LIKELIHOOD MASK 2.80 49.40 5 2259 56 0 2198 0.020 0.022 2299 2.260 2.009 3106 7.451 5.000 278 36.965 24.271 96 21.074 15.000 414 20.920 15.000 13 0.122 0.200 339 0.007 0.020 1694 0.277 0.200 1176 0.331 0.200 1559 0.177 0.200 113 0.003 0.200 1 0.260 0.200 22 0.101 0.200 5 0.813 1.500 1410 1.499 2.000 2244 2.261 3.000 987 3.701 4.500 860 0.421 0.303 2.873 32 585 20 100.00 2.80 49.39 4AN9 8366 2.0 0.12 1 11.30 5.4 99.8 0.82 2.80 2.95 2.30 1 5.5 100.0 refinement REFMAC 5.2.0005 data reduction MOSFLM data scaling SCALA phasing MOLREP DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (E.C.2.7.12.2) Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs. 1 N N 2 N N 3 N N 4 N N 5 N N A PRO 105 A PRO 48 HELX_P A LEU 115 A LEU 58 1 1 11 A GLN 116 A GLN 59 HELX_P A CYS 121 A CYS 64 5 2 6 A SER 150 A SER 93 HELX_P A GLY 159 A GLY 102 1 3 10 A PRO 162 A PRO 105 HELX_P A LYS 185 A LYS 128 1 4 24 A LYS 192 A LYS 135 HELX_P A SER 194 A SER 137 5 5 3 A SER 212 A SER 155 HELX_P A GLU 218 A GLU 161 1 6 7 A THR 226 A THR 169 HELX_P A MET 230 A MET 173 5 7 5 A SER 231 A SER 174 HELX_P A GLN 236 A GLN 179 1 8 6 A VAL 242 A VAL 185 HELX_P A GLY 259 A GLY 202 1 9 18 A ALA 309 A ALA 210 HELX_P A GLU 320 A GLU 221 1 10 12 A SER 331 A SER 232 HELX_P A LEU 342 A LEU 243 1 11 12 A ASP 351 A ASP 252 HELX_P A VAL 357 A VAL 258 1 12 7 A HIS 358 A HIS 259 HELX_P A GLU 367 A GLU 268 1 13 10 A ASP 370 A ASP 271 HELX_P A GLY 380 A GLY 281 1 14 11 metalc 2.209 A ASN 195 A OD1 ASN 138 1_555 A MG 1383 C MG MG 1_555 metalc 1.988 A ASP 208 A OD2 ASP 151 1_555 A MG 1383 C MG MG 1_555 metalc 2.006 A ACP 1382 B O1B ACP 1_555 A MG 1383 C MG MG 1_555 metalc 2.090 A ACP 1382 B O1A ACP 1_555 A MG 1383 C MG MG 1_555 metalc 2.177 A MG 1383 C MG MG 1_555 A HOH 2003 E O HOH 1_555 TRANSFERASE TRANSFERASE, MAP2K1, ATP-BINDING, ALLOSTERIC INHIBITION MP2K1_HUMAN UNP 1 Q02750 61 262 4AN9 61 262 Q02750 A 1 4 205 305 392 4AN9 305 392 Q02750 A 1 206 293 1 expression tag MET 58 4AN9 A Q02750 UNP 1 1 expression tag ALA 59 4AN9 A Q02750 UNP 2 1 expression tag LEU 60 4AN9 A Q02750 UNP 3 1 expression tag GLU 393 4AN9 A Q02750 UNP 294 1 expression tag GLY 394 4AN9 A Q02750 UNP 295 1 expression tag HIS 395 4AN9 A Q02750 UNP 296 1 expression tag HIS 396 4AN9 A Q02750 UNP 297 1 expression tag HIS 397 4AN9 A Q02750 UNP 298 1 expression tag HIS 398 4AN9 A Q02750 UNP 299 1 expression tag HIS 399 4AN9 A Q02750 UNP 300 1 expression tag HIS 400 4AN9 A Q02750 UNP 301 1 SER engineered mutation GLU 218 4AN9 A Q02750 UNP 218 161 1 SER engineered mutation GLU 222 4AN9 A Q02750 UNP 222 165 1 GLY engineered mutation ALA 328 4AN9 A Q02750 UNP 328 229 5 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A PHE 68 A PHE 11 A GLY 77 A GLY 20 A GLY 80 A GLY 23 A HIS 87 A HIS 30 A VAL 93 A VAL 36 A HIS 100 A HIS 43 A GLU 138 A GLU 81 A GLU 144 A GLU 87 A PHE 129 A PHE 72 A SER 135 A SER 78 A ILE 196 A ILE 139 A ASN 199 A ASN 142 A GLU 203 A GLU 146 A LEU 206 A LEU 149 BINDING SITE FOR RESIDUE ACP A 1382 Software 19 BINDING SITE FOR RESIDUE MG A 1383 Software 4 BINDING SITE FOR RESIDUE 2P7 A 1384 Software 13 A LEU 74 A LEU 17 19 1_555 A GLY 75 A GLY 18 19 1_555 A ALA 76 A ALA 19 19 1_555 A GLY 77 A GLY 20 19 1_555 A ASN 78 A ASN 21 19 1_555 A ALA 95 A ALA 38 19 1_555 A LYS 97 A LYS 40 19 1_555 A MET 143 A MET 86 19 1_555 A GLU 144 A GLU 87 19 1_555 A MET 146 A MET 89 19 1_555 A SER 150 A SER 93 19 1_555 A GLN 153 A GLN 96 19 1_555 A LYS 192 A LYS 135 19 1_555 A SER 194 A SER 137 19 1_555 A ASN 195 A ASN 138 19 1_555 A LEU 197 A LEU 140 19 1_555 A ASP 208 A ASP 151 19 1_555 A MG 1383 C MG 19 1_555 A HOH 2003 E HOH 19 1_555 A ASN 195 A ASN 138 4 1_555 A ASP 208 A ASP 151 4 1_555 A ACP 1382 B ACP 4 1_555 A HOH 2003 E HOH 4 1_555 A LYS 97 A LYS 40 13 1_555 A LEU 115 A LEU 58 13 1_555 A LEU 118 A LEU 61 13 1_555 A ILE 141 A ILE 84 13 1_555 A MET 143 A MET 86 13 1_555 A ASP 190 A ASP 133 13 1_555 A ASN 195 A ASN 138 13 1_555 A ASP 208 A ASP 151 13 1_555 A PHE 209 A PHE 152 13 1_555 A GLY 210 A GLY 153 13 1_555 A VAL 211 A VAL 154 13 1_555 A SER 212 A SER 155 13 1_555 A LEU 215 A LEU 158 13 1_555 169 P 61